26 related articles for article (PubMed ID: 3162646)
1. A rare presentation of BCR-ABL1 and RUNX1-MECOM rearrangement in a pediatric patient with acute myeloid leukemia.
Alamri RM; Alanazi M; AlRajeh RK; Tashkandi SA; Alswayyed AF; Samman MA; Peer-Zada AA
Clin Case Rep; 2024 May; 12(5):e8917. PubMed ID: 38751957
[TBL] [Abstract][Full Text] [Related]
2. EVI1 in Leukemia and Solid Tumors.
Liang B; Wang J
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962037
[TBL] [Abstract][Full Text] [Related]
3. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.
Branford S; Kim DDH; Apperley JF; Eide CA; Mustjoki S; Ong ST; Nteliopoulos G; Ernst T; Chuah C; Gambacorti-Passerini C; Mauro MJ; Druker BJ; Kim DW; Mahon FX; Cortes J; Radich JP; Hochhaus A; Hughes TP;
Leukemia; 2019 Aug; 33(8):1835-1850. PubMed ID: 31209280
[TBL] [Abstract][Full Text] [Related]
4. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
Mitani K; Ogawa S; Tanaka T; Miyoshi H; Kurokawa M; Mano H; Yazaki Y; Ohki M; Hirai H
EMBO J; 1994 Feb; 13(3):504-10. PubMed ID: 8313895
[TBL] [Abstract][Full Text] [Related]
5. Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia.
Rubin CM; Larson RA; Bitter MA; Carrino JJ; Le Beau MM; Diaz MO; Rowley JD
Blood; 1987 Nov; 70(5):1338-42. PubMed ID: 3478099
[TBL] [Abstract][Full Text] [Related]
6. A t (11;21) (13;q22) in Ph-positive chronic myelogenous leukemia.
Wang TY; Raza A; Sait SN; Stein A; Schumer J; Sandberg AA
Cancer Genet Cytogenet; 1988 Apr; 31(2):187-91. PubMed ID: 3162392
[TBL] [Abstract][Full Text] [Related]
7. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
8. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
9. t(4;21) (p16;q22) in blastic crisis of a chronic myeloid leukemia with variant Philadelphia translocation.
Donti E; Tabilio A; Rosetti A; Carotti A; Bordoni S; Falzetti F; Venti Donti G
Leuk Res; 1986; 10(12):1487-91. PubMed ID: 3467145
[TBL] [Abstract][Full Text] [Related]
10. Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis.
Coyle T; Najfeld V
Am J Hematol; 1988 Jan; 27(1):56-9. PubMed ID: 3162646
[TBL] [Abstract][Full Text] [Related]
11. Translocation (3;21)(q26;q22) in secondary leukemia. Report of two cases and literature review.
Schneider NR; Bowman WP; Frenkel EP
Ann Genet; 1991; 34(3-4):256-63. PubMed ID: 1809236
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
